159 related articles for article (PubMed ID: 14550505)
1. cDNA microarray and proteomic approaches in the study of brain diseases: focus on schizophrenia and Alzheimer's disease.
Marcotte ER; Srivastava LK; Quirion R
Pharmacol Ther; 2003 Oct; 100(1):63-74. PubMed ID: 14550505
[TBL] [Abstract][Full Text] [Related]
2. From proteomics to biomarker discovery in Alzheimer's disease.
Ho L; Sharma N; Blackman L; Festa E; Reddy G; Pasinetti GM
Brain Res Brain Res Rev; 2005 Apr; 48(2):360-9. PubMed ID: 15850675
[TBL] [Abstract][Full Text] [Related]
3. DNA microarrays in neuropsychopharmacology.
Marcotte ER; Srivastava LK; Quirion R
Trends Pharmacol Sci; 2001 Aug; 22(8):426-36. PubMed ID: 11479006
[TBL] [Abstract][Full Text] [Related]
4. Large-scale microarray studies of gene expression in multiple regions of the brain in schizophrenia and Alzheimer's disease.
Katsel PL; Davis KL; Haroutunian V
Int Rev Neurobiol; 2005; 63():41-82. PubMed ID: 15797465
[No Abstract] [Full Text] [Related]
5. HIV-associated dementia, Alzheimer's disease, multiple sclerosis, and schizophrenia: gene expression review.
Minagar A; Shapshak P; Duran EM; Kablinger AS; Alexander JS; Kelley RE; Seth R; Kazic T
J Neurol Sci; 2004 Sep; 224(1-2):3-17. PubMed ID: 15450765
[TBL] [Abstract][Full Text] [Related]
6. Preliminary studies on Alzheimer's disease using cDNA microarrays.
Wang G; Zhang Y; Chen B; Cheng J
Mech Ageing Dev; 2003 Jan; 124(1):115-24. PubMed ID: 12618014
[TBL] [Abstract][Full Text] [Related]
7. [Proteomics: biomarker research in psychiatry].
Hünnerkopf R; Grassl J; Thome J
Fortschr Neurol Psychiatr; 2007 Oct; 75(10):579-86. PubMed ID: 17566964
[TBL] [Abstract][Full Text] [Related]
8. Expression profiling of fibroblasts identifies cell cycle abnormalities in schizophrenia.
Wang L; Lockstone HE; Guest PC; Levin Y; Palotás A; Pietsch S; Schwarz E; Rahmoune H; Harris LW; Ma D; Bahn S
J Proteome Res; 2010 Jan; 9(1):521-7. PubMed ID: 19916557
[TBL] [Abstract][Full Text] [Related]
9. Incipient Alzheimer's disease: microarray correlation analyses reveal major transcriptional and tumor suppressor responses.
Blalock EM; Geddes JW; Chen KC; Porter NM; Markesbery WR; Landfield PW
Proc Natl Acad Sci U S A; 2004 Feb; 101(7):2173-8. PubMed ID: 14769913
[TBL] [Abstract][Full Text] [Related]
10. From cDNA microarrays to high-throughput proteomics. Implications in the search for preventive initiatives to slow the clinical progression of Alzheimer's disease dementia.
Pasinetti GM; Ho L
Restor Neurol Neurosci; 2001; 18(2-3):137-42. PubMed ID: 11847436
[TBL] [Abstract][Full Text] [Related]
11. High throughput approaches in neuroscience.
Morris CM; Wilson KE
Int J Dev Neurosci; 2004 Nov; 22(7):515-22. PubMed ID: 15465281
[TBL] [Abstract][Full Text] [Related]
12. The neuroproteomics of schizophrenia.
English JA; Pennington K; Dunn MJ; Cotter DR
Biol Psychiatry; 2011 Jan; 69(2):163-72. PubMed ID: 20887976
[TBL] [Abstract][Full Text] [Related]
13. Systems biology in the study of neurological disorders: focus on Alzheimer's disease.
Pasinetti GM; Hiller-Sturmhöfel S
Alcohol Res Health; 2008; 31(1):60-5. PubMed ID: 23584752
[TBL] [Abstract][Full Text] [Related]
14. Model-guided microarray implicates the retromer complex in Alzheimer's disease.
Small SA; Kent K; Pierce A; Leung C; Kang MS; Okada H; Honig L; Vonsattel JP; Kim TW
Ann Neurol; 2005 Dec; 58(6):909-19. PubMed ID: 16315276
[TBL] [Abstract][Full Text] [Related]
15. Data mining of gene expression changes in Alzheimer brain.
Walker PR; Smith B; Liu QY; Famili AF; Valdés JJ; Liu Z; Lach B
Artif Intell Med; 2004 Jun; 31(2):137-54. PubMed ID: 15219291
[TBL] [Abstract][Full Text] [Related]
16. A gene expression profile of Alzheimer's disease.
Loring JF; Wen X; Lee JM; Seilhamer J; Somogyi R
DNA Cell Biol; 2001 Nov; 20(11):683-95. PubMed ID: 11788046
[TBL] [Abstract][Full Text] [Related]
17. Harnessing the power of gene microarrays for the study of brain aging and Alzheimer's disease: statistical reliability and functional correlation.
Blalock EM; Chen KC; Stromberg AJ; Norris CM; Kadish I; Kraner SD; Porter NM; Landfield PW
Ageing Res Rev; 2005 Nov; 4(4):481-512. PubMed ID: 16257272
[TBL] [Abstract][Full Text] [Related]
18. Advances in spotted microarray resources for expression profiling.
Lyons P
Brief Funct Genomic Proteomic; 2003 Apr; 2(1):21-30. PubMed ID: 15239940
[TBL] [Abstract][Full Text] [Related]
19. Gene expression biomarkers in the brain of a mouse model for Alzheimer's disease: mining of microarray data by logic classification and feature selection.
Arisi I; D'Onofrio M; Brandi R; Felsani A; Capsoni S; Drovandi G; Felici G; Weitschek E; Bertolazzi P; Cattaneo A
J Alzheimers Dis; 2011; 24(4):721-38. PubMed ID: 21321390
[TBL] [Abstract][Full Text] [Related]
20. Proteomic approaches in brain research and neuropharmacology.
Vercauteren FG; Bergeron JJ; Vandesande F; Arckens L; Quirion R
Eur J Pharmacol; 2004 Oct; 500(1-3):385-98. PubMed ID: 15464047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
